Search clinical trials for: subcutaneous tocilizumab

Total 1230 results

Beneficência Portuguesa de São Paulo
Federal University of São Paulo; Hospital Israelita Albert Einstein; Hospital... and other collaborators

Terminated

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers (TOCIBRAS)

COVID | Cytokine Release Syndrome | SARS Pneumonia

Brazil
Hoffmann-La Roche

Completed

A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) (focuSSced)

Systemic Sclerosis

Belgium, United Kingdom, Mexico, Poland, United States, Japan, Argentina, Netherlands, Canada, France, Lithuania, Germany, Spain, Bulgaria, Denmark, Greece, Hungary, Italy, Portugal, Puerto Rico, Romania, Switzerland
University of California, Los Angeles
Genentech, Inc.

Completed

Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab (RASTS)

Rheumatoid Arthritis

United States
NYU Langone Health
Genentech, Inc.

Terminated

Tocilizumab for the Treatment of Behcet's Syndrome

Behcet Syndrome

United States
Hoffmann-La Roche

Completed

A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Argentina
Hoffmann-La Roche

Completed

Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

Austria
Hoffmann-La Roche

Completed

An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment

Rheumatoid Arthritis

Tunisia
Chugai Pharmaceutical

Completed

PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)

Rheumatoid Arthritis

Japan
AO GENERIUM

Recruiting

A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers

Healthy Volunteers

Russian Federation
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects

Healthy Subjects | Pharmacokinetics of ASP6294

United Kingdom
AlRefaey Kandeel

Completed

Subcutaneous NTG for US Radial Artery Cannulation (NTG-US-art)

Morbid Obesity
Tang-Du Hospital

Recruiting

Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis (tMG)

Myasthenia Gravis, Generalized

China
Chester Oddis
Genentech, Inc.

Completed

Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis (TIM)

Dermatomyositis | Polymyositis

United States
Hoffmann-La Roche

Completed

A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis

United States, Canada, United Kingdom, Brazil, Argentina, Germany, Italy, Russian Federation, Spain, Mexico, Australia, France
Hoffmann-La Roche

Completed

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNF

Rheumatoid Arthritis

Saudi Arabia
Hoffmann-La Roche

Completed

A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Philippines
Hoffmann-La Roche

Completed

A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis.

Rheumatoid Arthritis

Israel
Hoffmann-La Roche

Completed

A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).

Rheumatoid Arthritis

France
Hoffmann-La Roche

Completed

A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

Hungary
Hoffmann-La Roche

Completed

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study

Juvenile Idiopathic Arthritis

Germany
Hoffmann-La Roche

Completed

A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

Spain
Hoffmann-La Roche

Completed

Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine

Rheumatoid Arthritis

Germany
Genentech, Inc.

Completed

A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

United States, Puerto Rico
Hoffmann-La Roche

Completed

A Study of the Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs.

Rheumatoid Arthritis

United Kingdom
Hoffmann-La Roche

Completed

A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Spain
Hoffmann-La Roche

Completed

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)

Rheumatoid Arthritis

Morocco
University Hospital of Patras

Completed

Tocilizumab Versus Baricitinib in Patients With Severe COVID-19

COVID-19

Greece
Peking Union Medical College Hospital

Completed

Pilot Study of Tocilizumab Monotherapy for Active Chronic Periaortitis

Chronic Periaortitis | Tocilizumab Monotherapy

China
Massachusetts General Hospital
Genentech, Inc.; Brigham and Women's Hospital

Terminated

Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis
Brigham and Women's Hospital

Terminated

Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder

Major Depressive Disorder

United States
Hoffmann-La Roche

Completed

An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)

Giant Cell Arteritis

France
University of Calgary

Unknown

Tocilizumab in Coronavirus-19 Positive Patients

COVID-19 | Inflammation | Covid19 | Coronavirus | Severe Acute Respiratory Syndrome Coronavirus 2
Medical College of Wisconsin

Terminated

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

Acute Graft Versus Host Disease

United States
Eric B. Suhler
Genentech, Inc.

Terminated

Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis

Juvenile Idiopathic Arthritis Associated Uveitis

United States
Hoffmann-La Roche

Completed

A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy

Rheumatoid Arthritis

Belgium
University of Nebraska

Unknown

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study (STOP-Uveitis)

Posterior Uveitis | Intermediate Uveitis | Pan-uveitis

United States
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Study of MRA in Patients With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Polyarticular Juvenile Idiopathic Arthritis
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals

Completed

Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)

Treatment-Resistant Depression

Spain, Japan, Poland, United States
National Institute of Allergy and Infectious Diseases...
PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)

Completed

Tocilizumab (TCZ) in New-onset Type 1 Diabetes (EXTEND)

Type 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes Mellitus

United States, Australia
Ain Shams Maternity Hospital

Completed

Role of Subcutaneous Negative Pressure Suction Drain Placed for Ten Days on Wound Healing in Obese Patients Undergoing Midline Laparotomies

Postoperative Wound Healing

Egypt
Menoufia University

Completed

Subcutaneous Drains And Cesarean Section

Cesarean Section

Egypt
University Hospital, Limoges

Terminated

Oedematous Lower Limb Subcutaneous Drainage in Palliative Care (DSOPAL)

Edema

France
Boston Scientific Corporation

Completed

ECG Signal Collection From Long QT Syndrome, Wide QRS Complexes, Heart Failure, and Cardiac Resynchronization Patients

Heart Failure | Long QT Syndrome | Wide QRS Complexes | Cardiac Resynchronisation

United Kingdom
Ain Shams University

Completed

Closure Versus Non Closure of Subcutaneous Tissue After Cesarean Section in Diabetic Patients

Abdominal Delivery

3

Subscribe